NCT02911350View on ClinicalTrials.gov

Safety Study of Combination of Hormone Therapy, Paclitaxel and Radiation Therapy to Treat Prostate Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

May 31, 2000

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Prostate Cancer
Interventions
DRUG

Hormone Suppressors

DRUG

Paclitaxel

RADIATION

Radiation Therapy

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT02911350 - Safety Study of Combination of Hormone Therapy, Paclitaxel and Radiation Therapy to Treat Prostate Cancer | Biotech Hunter | Biotech Hunter